Opened in 1997, the Candiolo Institute is an oncological centre dedicated to clinical-healthcare activities and to scientific research.

In 2013 it was granted the status of IRCCS (Institute for Admission and Care for Purposes of Scientific Advancement). It performs its activities both in arrangement with the Italian National Health Service and with private patients .

In 2016 it obtained ISO quality certification 9001:2015 for all its areas of activity: diagnosis, treatment, assistance, research, administration, training, ethical committee.

The care pathway of the patient undergoing a haematopoietic bone marrow transplant has obtained the prestigious international JACIE-FACT accreditation. In addition, the Institute can boast HIMSS (Healthcare Information Management Systems Society) certification reflecting high technological standards and security with in questions of digitization of clinical and administrative documentation.

The Candiolo Institute has become, on the basis of a specific resolution of the Piedmont Regional Government dated 23.11.2015, a centre of reference for onco-haematological tumours, breast cancers, gynaecological tumours, colorectal tumours, tumours of the stomach, otorhinolaryngological tumours, urological tumours, skin cancers, sarcomas, tumours of the liver and of the intrahepatic bile ducts and tumours of the pancreas and of the extrahepatic bile ducts. In the course of 2015 Candiolo IRCCS also earned the role of regional single-specialty centre of reference for the management of oncological pain (DGR 29.12.2015).

The IRCCS is authorized and accredited by the regional healthcare authority for the management of 150 beds: 70 in the medical area, 70 in surgery, and 10 in intensive care.

In medical oncology, in addition to traditional chemotherapy, molecularly targeted therapies and immunotherapeutic treatments are also performed.

Candiolo Cancer Institute IRCCS

Similar companies